These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28296808)

  • 1. Waitlisted Candidates With Polycystic Liver Disease Are More Likely to be Transplanted Than Those With Chronic Liver Failure.
    Doshi SD; Bittermann T; Schiano TD; Goldberg DS
    Transplantation; 2017 Aug; 101(8):1838-1844. PubMed ID: 28296808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portal hypertension in polycystic liver disease patients does not affect wait-list or immediate post-liver transplantation outcomes.
    Rajoriya N; Tripathi D; Leithead JA; Gunson BK; Lord S; Ferguson JW; Hirschfield GM
    World J Gastroenterol; 2016 Dec; 22(45):9966-9973. PubMed ID: 28018103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
    Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable Use of Model for End-Stage Liver Disease Exception Points in Patients With Neuroendocrine Tumors Metastatic to the Liver and Its Impact on Patient Outcomes.
    Nobel YR; Goldberg DS
    Transplantation; 2015 Nov; 99(11):2341-6. PubMed ID: 25989503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Center variation in the use of nonstandardized model for end-stage liver disease exception points.
    Goldberg DS; Makar G; Bittermann T; French B
    Liver Transpl; 2013 Dec; 19(12):1330-42. PubMed ID: 24039090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to Liver Transplantation in Different ABO-Blood Groups and "Exceptions Points" in a Model for End-Stage Liver Disease Allocation System: A Brazilian Single-Center Study.
    Martino RB; Waisberg DR; Dias APM; Inoue VBS; Arantes RM; Haddad LBP; Rocha-Santos V; Pinheiro RSN; Nacif LS; D'Albuquerque LAC
    Transplant Proc; 2018 Apr; 50(3):754-757. PubMed ID: 29661430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation in adult polycystic liver disease: the Ontario experience.
    Alsager M; Neong SF; Gandhi R; Teriaky A; Tang E; Skaro A; Qumosani K; Lilly L; Galvin Z; Selzner N; Bhat MP; Puka K; Brahmania M
    BMC Gastroenterol; 2021 Mar; 21(1):115. PubMed ID: 33750299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical management of polycystic liver disease.
    Russell RT; Pinson CW
    World J Gastroenterol; 2007 Oct; 13(38):5052-9. PubMed ID: 17876869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of model for end-stage liver disease exceptions for donation after cardiac death graft recipients relisted for liver transplantation.
    Maduka RC; Abt PL; Goldberg DS
    Liver Transpl; 2015 Apr; 21(4):554-60. PubMed ID: 25597393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Population-based Data to Demonstrate How Waitlist-based Metrics Overestimate Geographic Disparities in Access to Liver Transplant Care.
    Goldberg DS; French B; Sahota G; Wallace AE; Lewis JD; Halpern SD
    Am J Transplant; 2016 Oct; 16(10):2903-2911. PubMed ID: 27062327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living donor liver transplantation in polycystic liver disease.
    Mekeel KL; Moss AA; Reddy KS; Douglas DD; Vargas HE; Carey EJ; Byrne TJ; Harrison ME; Rakela J; Mulligan DC
    Liver Transpl; 2008 May; 14(5):680-3. PubMed ID: 18433036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the management of the liver transplant patient.
    Kwong AJ; Fix OK
    Curr Opin Gastroenterol; 2015 May; 31(3):224-32. PubMed ID: 25774445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Ghabril M; Agarwal S; Lacerda M; Chalasani N; Kwo P; Tector AJ
    Transplantation; 2016 Jan; 100(1):126-33. PubMed ID: 26050013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported outcomes in liver transplant recipients with hepatocellular carcinoma.
    Kensinger CD; Feurer ID; O'Dell HW; LaNeve DC; Simmons L; Pinson CW; Moore DE
    Clin Transplant; 2016 Sep; 30(9):1036-45. PubMed ID: 27291713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
    Hoevenaren IA; Wester R; Schrier RW; McFann K; Doctor RB; Drenth JP; Everson GT
    Liver Int; 2008 Feb; 28(2):264-70. PubMed ID: 17927714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver and kidney transplantation for polycystic disease.
    Jeyarajah DR; Gonwa TA; Testa G; Abbasoglu O; Goldstein R; Husberg BS; Levy MF; Klintmalm GB
    Transplantation; 1998 Aug; 66(4):529-32. PubMed ID: 9734499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for the referring physician.
    Xu MM; Brown RS
    Clin Liver Dis; 2015 Feb; 19(1):135-53. PubMed ID: 25454301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined liver-kidney transplantation for polycystic liver and kidney disease: analysis from the United Network for Organ Sharing dataset.
    Coquillard C; Berger J; Daily M; Shah M; Mei X; Marti F; Gedaly R
    Liver Int; 2016 Jul; 36(7):1018-25. PubMed ID: 26663575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes utilizing imported liver grafts for recipients with hepatocellular carcinoma.
    Battula N; Reichman TW; Amiri Y; Carmody IC; Galliano G; Seal J; Bugeaud E; Bohorquez H; Bruce D; Cohen A; Loss GE
    Liver Transpl; 2017 Mar; 23(3):299-304. PubMed ID: 28026108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
    Cejas NG; Villamil FG; Lendoire JC; Tagliafichi V; Lopez A; Krogh DH; Soratti CA; Bisigniano L
    Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.